Clopidogrel - paediatric investigation plan

clopidogrel

Key facts

• Invented name:
  • Clopidogrel BMS
  • Clopidogrel BMS
• Active Substance:
  clopidogrel
• Therapeutic area:
  Cardiovascular diseases
• Decision number:
  P/190/2009
• PIP number:
  Clopidogrel
• Pharmaceutical form(s):
  • Age-appropriate oral formulation
  • Film-coated tablet
• Condition(s) / indication(s):
  Thromboembolic events
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  22/09/2009

Decision

P/190/2009: European Medicines Agency decision of 22 September 2009 on the agreement of a Paediatric Investigation Plan and on the granting of a deferral and on the granting of a waiver for clopidogrel (Clopidogrel BMS) ...

AdoptedReference Number: EMEA/583696/2009